Bolt Biotherapeutics (BOLT) Earnings Date & Reports
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
BOLT is expected to report earnings to rise 6.03% to -30 cents per share on August 06
Q2'25
Est.
$-0.31
Q1'25
Beat
by $0.12
Q4'24
Missed
by $0.06
Q3'24
Missed
by $0.06
Q2'24
Missed
by $0.10
The last earnings report on May 13 showed earnings per share of -28 cents, beating the estimate of -40 cents. With 972.97K shares outstanding, the current market capitalization sits at 12.38M.